We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Avastin, Herceptin Biosimilars Get OKs From FDA Advisory Committee
Avastin, Herceptin Biosimilars Get OKs From FDA Advisory Committee
An FDA advisory panel unanimously recommended that the agency approve two biosimilars for the cancer treatments Avastin (bevacizumab) and Herceptin (trastuzumab).